Form D · Biotechnology
Acworth Pharmaceuticals, Inc.
Cambridge, MA · CIK 0001736361
Offering snapshot reported May 7, 2021 · SEC filing
- Reported sold
- $352K Offering amount: $500K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2021 | Initial | $352,181 | No comparison | Not reported | SEC filing |
| Jan 28, 2020 | Initial | $600,000 | No comparison | 18 | SEC filing |
| Apr 5, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-398646
Source: Form D, filed May 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Leonard | Executive, Promoter |
| Edward W. Marple | Director, Executive, Promoter |
| Travis Metz | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Labcentral 700 Main Street
Cambridge, MA, 02139
Cambridge, MA, 02139